Adaptive Biotechnologies Corp 10-K filing
Filed 2026-02-26 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-076902
- Form type
- 10-K
- CIK
- 0001478320
- Primary document
- https://www.sec.gov/Archives/edgar/data/1478320/000119312526076902/adpt-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Adaptive Biotechnologies Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $277.0M | - | - |
| Cost Of Revenue | $71.4M | - | - |
| Operating Income | $-57.1M | - | - |
| Net Income | $-59.5M | - | - |
| Eps Basic | -0.39 | - | - |
| Eps Diluted | -0.39 | - | - |
| Cash And Equivalents | $70.5M | - | - |
| Total Assets | $512.7M | - | - |
| Total Liabilities | $287.7M | - | - |
| Shareholders Equity | $218.8M | - | - |
| Operating Cash Flow | $-46.0M | - | - |
| Capital Expenditures | $3.0M | - | - |